Effectiveness of Benralizumab in Severe Eosinophilic Asthma Under Conditions of Routine Clinical Practice

被引：3

作者：

Lopez, J. C. Miralles ^{[1
]}

Andujar-Espinosa, R. ^{[2
]}

Bravo-Gutierrez, F. J. ^{[3
]}

Castilla-Martinez, M. ^{[4
]}

Flores-Martin, I ^{[5
]}

Alemany-Frances, M. L. ^{[6
]}

Pajaron-Fernandez, M. J. ^{[7
]}

Gonzalez, A. Mora ^{[8
]}

Valverde-Molina, J. ^{[9
]}

Perez-Fernandez, V ^{[10
]}

机构：

[1] Univ Gen Hosp Reina Sofia, Dept Allergy, Murcia, Spain

[2] Univ Clin Hosp Virgen de la Arrixaca, Dept Pulmonol, Murcia, Spain

[3] Univ Gen Hosp Santa Lucia, Dept Pulmonol, Murcia, Spain

[4] Univ Gen Hosp Los Arcos, Dept Pulmonol, Murcia, Spain

[5] Univ Gen Hosp Santa Lucia, Dept Allergy, Murcia, Spain

[6] Univ Gen Hosp Morales Meseguer, Dept Pulmonol, Murcia, Spain

[7] Hosp de la Vega, Dept Allergy, Murcia, Spain

[8] Univ Gen Hosp Morales Meseguer, Dept Allergy, Murcia, Spain

[9] Univ Gen Hosp Santa Lucia, Dept Pediat, Murcia, Spain

[10] Univ Murcia, Dept Publ Hlth Sci, Sch Med, Murcia, Spain

来源：

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY | 2022年 / 32卷 / 03期

关键词：

Severe asthma; Benralizumab; Eosinophils; Nasal polyps; ANTIBODY;

D O I：

10.18176/jiaci.0793

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：220 / 223

页数：4

共 12 条

[1] Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial [J].

Bleecker, Eugene R. ;

FitzGerald, J. Mark ;

Chanez, Pascal ;

Papi, Alberto ;

Weinstein, Steven F. ;

Barker, Peter ;

Sproule, Stephanie ;

Gilmartin, Geoffrey ;

Aurivillius, Magnus ;

Werkstrom, Viktoria ;

Goldman, Mitchell .

LANCET, 2016, 388 (10056) :2115-2127

[2] Selection of Biologics in Severe Asthma: A Multifaceted Algorithm [J].

Davila, I ;

Quirce, S. ;

Olaguibel, J. M. .

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (04) :325-328

[3] Clinical Recommendations for the Management of Biological Treatments in Severe Asthma Patients: A Consensus Statement [J].

Delgado, J. ;

Davila, I. J. ;

Dominguez-Ortega, J. .

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2021, 31 (01) :36-43

[4]

FitzGerald JM, 2016, LANCET, V388, P2128, DOI [10.1016/s0140-6736(16)31322-8, 10.1016/S0140-6736(16)31322-8]

[5] Benralizumab - a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity - a novel approach for the treatment of asthma [J].

Ghazi, Aasia ;

Trikha, Anita ;

Calhoun, William J. .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (01) :113-118

[6] Benralizumab: A New Approach for the Treatment of Severe Eosinophilic Asthma [J].

Gonzalez I, Davila ;

Benitez F, Moreno ;

Quirce, S. .

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (02) :84-93

[7] Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years [J].

Korn, Stephanie ;

Bourdin, Arnaud ;

Chupp, Geoffrey ;

Cosio, Borja G. ;

Arbetter, Doug ;

Shah, Mihir ;

Garcia Gil, Esther .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (12) :4381-+

[8] Postbronchodilator lung function improvements with benralizumab for patients with severe asthma [J].

Mathur, Sameer K. ;

Modena, Brian D. ;

Coumou, Hanneke ;

Barker, Peter ;

Kreindler, James L. ;

Zangrilli, James G. .

ALLERGY, 2020, 75 (06) :1507-1510

[9] Quality of life in severe asthmatic patients treated with benralizumab [J].

Miralles Lopez, J. C. ;

Escudero Pastor, A. I. ;

Carbonell Martinez, A. ;

Navarro Garrido, C. ;

Bonilla Pacheco, Y. ;

Petryk Petryk, Y. .

EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 54 (03) :144-146

[10] Benralizumab in Real Life [J].

Miralles Lopez, J. C. ;

Escudero Pastor, A., I ;

Carbonell Martinez, A. ;

Navarro Garrido, C. ;

Bonilla Pacheco, Y. ;

Petrik Petrik, Y. .

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2021, 31 (01) :87-88

← 1 2 →